Podcast Beta
Questions and Answers
What is the impact of insufficient sleep on weight management?
Which factor is NOT considered an environmental factor contributing to obesity?
What relationship exists between socioeconomic status and obesity prevalence?
Which group has been found to experience higher levels of body dissatisfaction?
Signup and view all the answers
What is the role of alcohol consumption in weight gain?
Signup and view all the answers
What is the most common cause of primary weight gain?
Signup and view all the answers
Which factor should NOT be assessed during patient intake for obesity?
Signup and view all the answers
What laboratory screening is essential for comorbid conditions in patients?
Signup and view all the answers
At what age range is weight gain typically highest among adults?
Signup and view all the answers
What psychosocial factor should be assessed during patient intake for obesity?
Signup and view all the answers
What is a likely environmental factor contributing to weight gain?
Signup and view all the answers
Which demographic trend indicates a tendency for weight loss?
Signup and view all the answers
What should be considered a significant risk factor when evaluating primary weight gain?
Signup and view all the answers
What percentage of patients with type 2 diabetes mellitus (T2DM) are also classified as obese?
Signup and view all the answers
Which risk factor is NOT associated with an increased likelihood of developing obstructive sleep apnea (OSA)?
Signup and view all the answers
Which of the following symptoms is most commonly associated with type 2 diabetes mellitus (T2DM)?
Signup and view all the answers
What is the primary method used to diagnose obstructive sleep apnea (OSA)?
Signup and view all the answers
Which of the following is a characteristic feature of non-alcoholic fatty liver disease (NAFLD)?
Signup and view all the answers
Which screening tool is validated for assessing the risk of obstructive sleep apnea (OSA)?
Signup and view all the answers
Which of the following statements about the prognosis of non-alcoholic fatty liver disease (NAFLD) is accurate?
Signup and view all the answers
When diagnosing T2DM, which of the following is an acceptable fasting blood glucose (FBG) level indicative of diabetes?
Signup and view all the answers
What is a common consequence of untreated obstructive sleep apnea (OSA)?
Signup and view all the answers
Which of the following measures is NOT a component of the STOP-Bang questionnaire?
Signup and view all the answers
Which bariatric procedure requires bone densitometry every 2 years during follow-up?
Signup and view all the answers
How often should vitamin B12 levels be monitored postoperatively in patients undergoing LAGB, LSG, RYGB, or BPD/BPD-DS?
Signup and view all the answers
Which laboratory evaluation is performed at each follow-up visit for all bariatric surgery procedures?
Signup and view all the answers
Which of the following vitamins is exempt from yearly monitoring in LAGB and LSG procedures?
Signup and view all the answers
What is the recommended follow-up interval after achieving stability for RYGB patients?
Signup and view all the answers
During follow-up, which procedure monitors both copper and zinc levels?
Signup and view all the answers
What is the primary focus of the 5As framework in obesity management?
Signup and view all the answers
What is the frequency requirement for lipid evaluation after bariatric surgery?
Signup and view all the answers
Which of the following symptoms is NOT considered a red flag finding for obesity complications?
Signup and view all the answers
What is the BMI classification for someone with a BMI of 36?
Signup and view all the answers
What percentage of breast cancer prevalence is attributed to obesity?
Signup and view all the answers
Which condition has the highest prevalence among the serious comorbid diseases in the obese population?
Signup and view all the answers
Among the following diseases, which one has the lowest proportion of prevalence attributable to obesity?
Signup and view all the answers
What is a common complication of obstructive sleep apnea related to obesity?
Signup and view all the answers
Which of the following risk factors has an age-adjusted relative risk of 2.75 for hypertension in females with a BMI ≥ 30?
Signup and view all the answers
Which class of obesity corresponds to a BMI of 29.8?
Signup and view all the answers
Which of the following conditions is listed as a comorbidity due to obesity and involves joint pain?
Signup and view all the answers
Chest tightness and pressure during emotional stress are indicative of which potential comorbidity?
Signup and view all the answers
What is the relative risk for diabetes mellitus in males with a BMI of ≥ 30?
Signup and view all the answers
Which obesity-related disease has a prevalence of 49 - 65% in the population?
Signup and view all the answers
How is the classification of obesity determined?
Signup and view all the answers
Which of the following is NOT typically categorized as a comorbidity of obesity?
Signup and view all the answers
Study Notes
Medical History
- Determine age of onset of weight gain
- Note recent weight changes, especially rapid gain
- Assess family history of obesity, as this may be a genetic predisposition
- Explore occupational history, as some occupations may contribute to weight gain
- Evaluate eating and exercise habits
- Inquire about previous weight loss attempts, including reasons why they may have been unsuccessful
- Assess psychosocial factors, including mood disorders and potential eating disorders
Primary Weight Gain
- Most common cause of weight gain, with women being more likely to gain weight than men
- Peaks between ages 24-34, with individuals over 55 years old more likely to lose weight
- Primary weight gain is due to an imbalance between caloric intake and energy expenditure
- Increased caloric intake is influenced by:
- Increased appetite
- Reduced physical activity levels
- Reduced basal metabolic rate (BMR)
- Reduced thermic effect of food
Environmental Factors Contributing to Weight Gain
-
Increased Caloric Intake:
- High consumption of refined grains, added sugars, and fats (e.g., processed and fast foods) is strongly associated with obesity.
-
Eating Patterns:
- Binge eating and night eating disorders can contribute to obesity.
-
Alcohol Consumption:
- Intake of "liquid calories," specifically heavy alcohol consumption, is associated with weight gain and obesity.
-
Insufficient Sleep:
- Associated with increased appetite and caloric intake.
-
Smoking Cessation:
- Can lead to an increased caloric intake and reduced energy expenditure, contributing to weight gain.
-
Sedentary Lifestyle:
- Prolonged television watching is associated with an increased risk of obesity, primarily due to a reduction in energy expenditure. This lifestyle choice also increases the risk of chronic diseases and overall mortality.
-
Physical Disability:
- Mobility problems can alter body composition and decrease energy expenditure, including limiting physical activity. This can lead to a higher prevalence of obesity.
-
Obesogenic Environment:
- Abundant food supplies, eating for pleasure and entertainment (rather than nutritional needs), and urban sprawl that discourages walkability are all obesogenic factors.
-
Society:
- An inverse relationship exists between socioeconomic status and obesity prevalence: lower income is often associated with higher rates of obesity.
- Variations in ethnicity and sex also impact obesity prevalence (e.g., morbid obesity is more common in women than men, and highest among Black adults compared to White, Asian, and Hispanic adults).
-
Culture:
- Bias, stigma, and discrimination surrounding weight can create emotional and psychological challenges for individuals. For example, White women are more likely to experience body dissatisfaction and feel overweight compared to Black and Hispanic women.
-
Environmental Chemicals:
- Endocrine-disrupting chemicals (e.g., diphenhydramine) and steroids like glucocorticoids (e.g., hydrocortisone, prednisone) are known to potentially contribute to weight gain.
Red Flags Findings
- Rapid weight gain over days to weeks
- Difficulty breathing or coughing at night
- Increased thirst or urination
- Inability to sleep lying flat
- Blurry vision
- Recent increases in waist or pant size
- Pain or stiffness in joints
- Yellowing of skin or whites of eyes (jaundice) or tea-coloured urine
- Prolonged or excessive bleeding
- Reduction in urination
- Nausea, vomiting, generalized itch
- Swelling in feet, ankles, or legs
Obesity Comorbidities
- Common health conditions associated with obesity:
- Coronary artery disease
- Congestive heart failure
- Stroke
- Emphysema, chronic bronchitis, or obstructive pulmonary disease
- Pulmonary embolism
- Deep vein thrombosis
- Cancer
- Diabetes
- Hypercholesterolemia
- Hypertension
- Depression
- Macular degeneration
- Cataract removal
- Neck, back, or joint pain
- Frequent headaches
- Stress
- Fatigue/lack of energy
- Feeling depressed/anxious
- Chronic insomnia
- Indigestion or heartburn
- Impotence
- Skin problems
- Bladder and yeast infections
- Osteoarthritis
- Gingivitis
- GERD
- Ulcers
- Gallbladder removal
- Pancreatitis
- Kidney disease (+ stones)
- Asthma
Classification of Obesity by BMI, WC, and Associated Disease Risk
- BMI (kg/m2) | Obesity Class | Male ≤102cm (40in) | Male >102cm (40in) | Female ≤88cm (35in) | Female >88cm (35in)
- ------ | -------- | -------- | -------- | -------- | -------- Underweight | < 18.5 | | | | | Normal | 18.5 - 24.9 | | Increased | | Increased | Overweight | 25.0 - 29.9 | Increased | High | Increased | High | Obesity | 30.0 - 34.9 | I | High | Very High | 35.0 - 39.9 | II | Very High | Very High | ≥40 | III | Extremely High | Extremely High | Extremely High | Extremely High
- Diseases associated with obesity: type 2 diabetes, hypertension, coronary heart disease
Proportion of Disease Prevalence Attributable to Obesity
- Type 2 diabetes: 61%
- Uterine cancer: 34%
- Gallbladder disease: 30%
- Osteoarthritis: 24%
- Hypertension: 17%
- Coronary heart disease: 17%
- Breast cancer: 11%
- Colon cancer: 11%
Serious Comorbid Disease Prevalence in Obese Population
- Type 2 diabetes: 7-20%
- Hypertension: 49-65%
- Hyperlipidemia: 34-41%
- Coronary heart disease: 10-19%
- Sleep apnea: 8-15%
- Osteoarthritis: 5-17%
- Non-alcoholic fatty liver disease (NAFLD): 60-90%
Physiological Effects of Obesity
- Increased cardiac output
- Increased metabolic rate
- Increased sympathetic tone
- Increased thyroid hormone
- Hyperinsulinemia
- Increased insulin resistance
- Increased visceral fat storage
- Decreased energy expenditure
- Increased sodium retention
- Increased portal blood free fatty acids
- Increased estrogen
- Decreased HDL cholesterol
- Increased LDL cholesterol
- Increased cholesterol excretion
- Increased vasoconstriction
- Increased risk of heart failure
- Increased risk of diabetes
- Increased risk of gallstones
- Increased risk of cancer
- Increased risk of hypertension
- Increased risk of coronary artery disease
Relative Risk (RR) of Obesity and Heart Disease Risk Factor Development
- Risk factor | Sex | BMI 25 - 29.9 | BMI ≥ 30
- ------ | -------- | -------- | -------- Hypertension ( >1 30/80 mmHg) | Male| 1.46 | 2.21 | Hypertension (> 130/80 mmHg) | Female | 1.75 | 2.75 | Hypercholesterolemia ( ↑ total, LDL chol.) | Male | 1.19 | 1.11 | Hypercholesterolemia ( ↑ total, LDL chol.) | Female | 1.35 | 1.16 | Diabetes mellitus ( ↑ FBG, HbA1c) | Male | 1.33 | 2.12 | Diabetes mellitus ( ↑ FBG, HbA1c) | Female | 0.97 | 1.42 |
Relative Risk (RR) of Obesity and Heart Disease
- Cardiovascular disease outcome | Sex | BMI 25 - 29.9 | BMI ≥ 30
- ------ | -------- | -------- | -------- Angina pectoris | Male | 1.47 | 1.81 | Angina pectoris | Female | 1.42 | 1.63 | Myocardial infarction (MI) | Male | 1.26 | 1.17 | Myocardial infarction (MI) | Female | 0.91 | 1.46 | Total coronary artery disease | Male | 1.43 | 1.58 | Total coronary artery disease | Female | 1.22 | 1.54 | Cerebrovascular disease | Male | 1.28 | 1.61 | Cerebrovascular disease | Female | 1.10 | 1.02 | Total heart disease | Male | 1.24 | 1.38 | Total heart disease | Female | 1.13 | 1.38 | Cardiovascular disease death | Male | 1.05 | 0.98 | Cardiovascular disease death | Female | 0.77 | 1.56 |
- Adjusted for age, smoking, hypertension, hypercholesterolemia, and diabetes.
Type 2 Diabetes Mellitus (T2DM)
- Chronic metabolic disorder characterized by persistent hyperglycemia, caused by ineffective response to insulin (insulin resistance)
- Makes up 90% of diabetes cases
- Prevalence in Canada: 8.8%
- Risk factors: obesity, unhealthy diet (high in ultra-processed foods), physical inactivity, lower socioeconomic status, increased age (over 45 years), family history, and ethnicity (increased risk among Black, South Asian, Indigenous peoples)
- Signs and symptoms: increased thirst, increased hunger, increased urination, fatigue, acanthosis nigricans, proneness to infections, delayed wound healing, potential peripheral neuropathy (numbness or tingling in hands/feet), or blurry vision
- Diagnosis: Hemoglobin A1c (HbA1c) or fasting blood glucose (FBG)
- FBG > 7.0 mmol/L OR HbA1c > 6.5%
- Management: Diet + lifestyle modification (weight loss)
- Prognosis: 15% higher mortality, increased risk of atherosclerotic cardiovascular disease
T2DM + Obesity
- 80% of patients with T2DM are obese
- 7-20% of obese adults have T2DM
Obstructive Sleep Apnea (OSA)
- Common, chronic disorder where patients temporarily stop or decrease breathing repeatedly during sleep
- Estimated prevalence: 2-14% of the population
- Risk factors: obesity, advanced age (40-70 years), male, supine sleep position, family history of OSA, retrognathia, commercial motor vehicle driver, postmenopausal women not on HRT
- Estimated prevalence in obese adults: 45%
- Signs and symptoms: gasping during sleep, morning headache, excessive daytime sleepiness, loud snoring
- Diagnosis: polysomnography
- Potential indicators: high body mass index (BMI), neck circumference > 40 cm (16 inches), chin position, narrow oropharyngeal opening
- Management: Referral for continuous positive airway pressure (CPAP) device
- Prognosis: Increased morbidity and mortality (estimated lifespan reduction of 20 years)
STOP-Bang Questionnaire
- Self-administered, validated questionnaire to screen for obstructive sleep apnea (OSA)
- "STOP" stands for: Snoring, Tiredness, Observed apnea, high blood Pressure
- "Bang" stands for: Body mass index (BMI), Age, Neck circumference, and Gender
- Scoring System:
- Sensitivity: 90.5% for all OSA in BMI ≥ 30, score ≥ 3
- Sensitivity: 95.8% for all OSA in BMI ≥ 35, score ≥ 3
- Sensitivity: 68.8% for severe OSA in BMI ≥ 30, score ≥ 5
- Sensitivity: 50.0% for severe OSA in BMI ≥ 35, score ≥ 5
Non-Alcoholic Fatty Liver Disease (NAFLD)
- Broad term covering a spectrum of conditions, characterized by hepatic steatosis on imaging or histology without secondary causes
- Risk factors: obesity, diabetes, dyslipidemia, insulin resistance, metabolic syndrome
- Prevalence in obese adults: 80-90%
- Signs and symptoms: usually asymptomatic, but may present with fatigue, right upper quadrant (RUQ) pain, thirst, bloating, sleep disturbance
- Diagnosis: ultrasound, liver biopsy
- Potential indicators: hepatomegaly, mildly elevated or normal ALT/AST, AST:ALT ratio > 1
- Management Algorithm:
- If BMI ≥ 25 OR ↑ WC, PLUS 2 or more risk factors of cardiovascular disease (CVD) + diabetes -> Assess risk
- If no, Advise to maintain weight; address other risk factors.
- If yes, and Hx of BMI ≥ 25, advise patient to maintain weight.
- If no, address other risk factors.
- If patient hasn't lost ≥0.5kg/wk after 6 months of lifestyle modification, requires lifelong monitoring.
Postoperative Follow-up for Bariatric Surgery
- The following table shows the recommended postoperative visit schedule for various bariatric surgery types:
- LAGB (laparoscopic adjustable gastric banding)
- LSG (laparoscopic sleeve gastrectomy)
- RYGB (laparascopic Roux-en-Y gastric bypass)
- BPD/BPD-DS (laparoscopic biliopancreatic diversion/BPD-duodenal switch)
- Follow-up schedule:
- Initial, interval until stable, once stable (months)
- LAGB: 1, 1-2, 12
- LSG: 1, 3-6, 12
- RYGB: 1, 3, 6-12
- BPD/BPD-DS: 1, 3, 6
- Initial, interval until stable, once stable (months)
- Blood work: CBC, chemistry panel with each visit (iron at baseline and prn)
- Lab tests:
- Lipid evaluation (every 6-12 months)
- Bone densitometry (every 2 years)
- 24-hour urinary excretion yearly (initial at 6 months)
- Vitamin B12 yearly (3-6 months if supplemented)
- Folic acid, iron, vitamin D, iPTH (RYGB, BPD/BPD-DS)
- Vitamin A (every 6-12 months) (optional for RYGB, required for BPD/BPD-DS)
- Copper, zinc, selenium (RYGB, BPD/BPD-DS)
- Thiamine (all types)
- Assessment for anti-hypertensives, gout therapy, and gallstone prophylaxis each visit
- Lab tests:
5As Framework for Obesity Management in Adults
- Ask: Ask permission to discuss weight with the patient. Be non-judgmental and explore their readiness for change.
- Assess: Assess BMI, waist circumference, and obesity class. Explore root causes of obesity.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.